These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 4154022

  • 1. Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic h-2-identical immunocompetent cells.
    Bortin MM, Rimm AA, Rose WC, Saltzstein EC.
    Transplantation; 1974 Sep; 18(3):280-3. PubMed ID: 4154022
    [No Abstract] [Full Text] [Related]

  • 2. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
    Bortin MM, Rimm AA, Saltzstein EC, Rodey GE.
    Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Graft versus leukemia for "cell cure" of long-passage AKR leukemia after chemoradiotherapy.
    Saltzstein EC, Glasspiegel JS, Rimm AA, Giller RH, Bortin MM.
    Cancer Res; 1972 Aug; 32(8):1658-62. PubMed ID: 4402951
    [No Abstract] [Full Text] [Related]

  • 5. Time pattern of the antileukemic effect of graft-versus-host reaction in mice.
    Boranić M, Tonković I.
    Cancer Res; 1971 Aug; 31(8):1140-7. PubMed ID: 4398523
    [No Abstract] [Full Text] [Related]

  • 6. Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma.
    Truitt RL, Rimm AA, Saltzstein EC, Rose WC, Bortin MM.
    Transplant Proc; 1976 Dec; 8(4):569-74. PubMed ID: 11589
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ, Esparza AR, Flinton LJ, Simon JD, Kelley RJ, Albala MM.
    Cancer Res; 1977 Oct; 37(10):3494-6. PubMed ID: 20223
    [Abstract] [Full Text] [Related]

  • 9. Resistance of guinea pigs to leukemia following transfer of immunocompetent allogeneic lymphoid cells.
    Katz DH, Ellman L, Paul WE, Green I, Benacerraf B.
    Cancer Res; 1972 Jan; 32(1):133-40. PubMed ID: 4400014
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An MHC-compatible allogeneic bone marrow donor with a distinct role of T cell subsets in graft-versus-leukemia effect and lethal graft-versus-host disease.
    Aizawa S, Kamisaku H, Sado T.
    Bone Marrow Transplant; 1995 Oct; 16(4):603-9. PubMed ID: 8528179
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide.
    Truitt RL, Rose WC, Rimm AA, Bortin MM.
    Exp Hematol; 1978 May; 6(5):488-98. PubMed ID: 26584
    [Abstract] [Full Text] [Related]

  • 19. Graft-versus-host reactions in mice. I. Kinetic and immunogenetic studies of alloantigen-sensitive units of lymphoid tissue.
    Bennett M.
    Transplantation; 1971 Feb; 11(2):158-69. PubMed ID: 4397088
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.